Naturally occurring phenethyl isothiocyanate inhibits gastric cancer cell growth by disruption of microtubules
The dietary plant phytochemical PEITC is thought to
contribute to chemoprevention against several types of human cancer diseases
alongside with other plant phytochemicals enriched in a diet with cruciferous
vegetables. Moreover, PEITC has also been suggested for clinical treatment of
cancer as it may cure resistance to cancer drugs and thus sensitize cancer
cells to these drugs22. It is therefore
important to understand the underlying mechanisms upon the PEITC-entry to a
cancer cell. In the present study we showed a disintegration of microtubular
filaments in gastric cancer cell line Kato-III as a mechanism presumably
contributing to the subsequent cell cycle arrest and apoptosis induced by
PEITC. Previous studies with ITCs and stomach cancer have shown an inverted
correlation between intake of ITC-rich diet and risk of cancer7. Furthermore, the
broccoli-derived sulforaphane was reported to eradicate the gastric
cancer-related bacterium H. pylori
from a gastric cancer cell line and presumably reduced the cell count of these
bacteria in the stomach of human patients18,
23.
Prevention of chemically induced gastric cancer in mice by SFN was linked to
the nrf2-gene as nrf2 knock out mice did not respond equally strong in cancer
prevention to an SFN-rich diet18.
To the best our knowledge, no in vivo
experiments on gastric cancer with PEITC have been reported so far, which we in
parallel to this study is currently undertaking. However, in in vitro studies, PEITC has been shown
to attenuate cell migration and invasion of human gastric cancer AGS cell line17.
Suppression of MAPK- and NFkB signalling pathways were pointed out as key
underlying factors. Similar findings were made when another aromatic ITC,
benzyl ITC, was applied to AGS cells24. Although our
findings are the first to show the loss of microtubular filaments in gastric
cancer cells treated with PEITC, in lung cancer cells, Mi and colleagues
identified alpha- and beta tubulins, monomers of microtubuli as binding targets
for PEITC12.
Moreover, in bladder cancer cells, binding of the aliphatic allyl ITC to alpha-
and beta tubulin led to subsequent ubiquitination and degradation of tubulins
as well as onset of a mitotic cell cycle arrest and ultimately apoptosis21. In prostate
cancer cells, PEITC was shown to induce G2/M cell cycle arrest as well as
downregulation of gene expression of alpha- and beta tubulins25.
In breast cancer cells, SFN was shown to suppress the dynamic instability of
microtubules leading to mitotic arrest of these cells26.
Taken together we suggest that PEITC binds to alpha- and beta tubulins with the
subsequent degradation of these monomers leading to a deformation of
microtubular filaments which in turn contributes to accumulation of cells in G2/M-phase
and apoptosis in gastric cancer cell line Kato-III. Upon entering a cell, PEITC
inevitably binds to the abundantly present redox mediator GSH. Binding and
conjugation with GSH leads to a decrease in the intracellular GSH-pool and
secondary effects including generation of ROS. It has been suggested that this
mechanism is essential in the selective toxicity of PEITC in cancerous cells
compared to their normal equivalents27.
Cell line MKN74 tested in the present study displayed a lower sensitivity to
PEITC when proliferation was assayed. Furthermore, these cells showed a weak
response in GSH-reduction, increase of apoptotic cells, and increase in
caspase-3 activity. When testing higher concentrations than those presented
here, we observed high amount of cell death and could not obtain reproducible
data. Different sensitivity among individual cell lines has also been observed
in human breast cancer cells in which a comparison of two cell lines revealed
the one to yield a higher IC50-value, lower increase in apoptotic
cells and a lower decrease in GSH-content following PEITC-treatment28. These
observations were accredited the elevated basal level of NRF2 in the lesser
sensitive cell line, as an elevated level of NRF2 also results in and increase
in GSH-level rendering the cells more resistant to PEITC. Important features of
cancerous cells are the elevated level of ROS27,
and the ability to promote NRF2-dependent ROS-detoxification29, which again
points to the importance of the basal GSH-level which presumably may vary with
cell types. Thus, the reduced sensitivity in MKN74 cells might be explained
through an elevated basal level of GSH-content in consistency with no elevation
of ROS-levels yet a weak but significant reduction in GSH-content following
PEITC-treatment. In conclusion, the present study demonstrates PEITC as a
potential inhibitor of gastric cancer cell growth, and presents new insight
into the underlying molecular mechanisms.
Post Comment
No comments